School of Medicine


Showing 3,561-3,580 of 4,930 Results

  • Sneha Ramakrishna

    Sneha Ramakrishna

    Assistant Professor of Pediatrics (Hematology/Oncology)

    BioSneha Ramakrishna obtained her B. A. from the University of Chicago and her M.D. from the Cleveland Clinic Lerner College of Medicine at Case Western Reserve University. In medical school, through the Howard Hughes Medical Research Scholar Award, she joined Dr. Crystal Mackall’s laboratory, where she designed and developed various GD2 CAR-Ts and tested them in preclinical models. During her residency training in Pediatrics at the Children’s Hospital of Philadelphia, she cared for some of the first patients treated with CD19 CAR T cells, learning the power of this therapy first-hand. During her fellowship in Pediatric Hematology/Oncology at the Johns Hopkins/National Cancer Institute combined program, she worked with Dr. Terry Fry. She evaluated the mechanism of CD22 CAR T cell relapse in patients by developing an antigen escape model and establishing a deeper understanding of the effects of antigen density on CAR-T phenotype, expansion, and persistence (Fry…Ramakrishna…Mackall Nat Med, 2018; Ramakrishna, et al., Clinical Cancer Research, 2019). Since arriving at Stanford, Dr. Ramakrishna leads an interdisciplinary team that designs, develops, and successfully implements a robust correlative science platform for our novel CAR-T therapies. Analyzing patient samples from our first-in-human GD2 CAR-T trial (NCT04196413) treating a universally fatal cancer, diffuse midline glioma (DMG), we identified that intracerebroventricular CAR-T administration correlates with enhanced pro-inflammatory cytokines and reduced immunosuppressive cell populations in cerebrospinal fluid as compared to intravenous CAR-T administration (Majzner*, Ramakrishna*, et al., Nature 2022 *co-first authors). Her research program evaluates unique sets of patient samples using novel single-cell immune profiling to identify the drivers of CAR-T success or failure. Building on these findings, her team assesses approaches to enhance CAR-T efficacy and translate these findings to the clinic.

    Clinically, Dr. Ramakrishna cares for children with solid tumors and treats hematologic, solid, and brain tumor pediatric patients with CAR T cell therapies in the Cancer Cellular Therapies program.

  • Chandra Ramamoorthy

    Chandra Ramamoorthy

    Professor of Anesthesiology, Perioperative and Pain Medicine (Pediatric), Emerita

    Current Research and Scholarly InterestsNeuro protection and neurologic outcomes in cardiac patients prior to and concurrent with cardiac surgery and catheterization

  • R J Ramamurthi

    R J Ramamurthi

    Clinical Professor, Anesthesiology, Perioperative and Pain Medicine

    Current Research and Scholarly InterestsProspective collection of pediatric regional block procedures and complications on to a national database

  • Ashwin Ramayya, MD, PhD

    Ashwin Ramayya, MD, PhD

    Assistant Professor of Neurosurgery

    BioDr. Ramayya is an assistant professor in the Department of Neurosurgery. He specializes in the treatment of patients with chronic pain, movement disorders, epilepsy, and traumatic brain injury. His research program will focus on understanding brain mechanisms underlying pain experience and how to alleviate pain using brain stimulation.

    Dr. Ramayya specializes in neuromodulation, including deep brain stimulation (DBS), spinal cord stimulation, MRI-guided laser therapy, and focused ultrasound. Dr. Ramayya obtained his MD and PhD from the University of Pennsylvania, where he also completed his neurosurgery residency and a fellowship in stereotactic and functional neurosurgery.

    His research efforts have identified neural substrates underlying learning, memory, and decision-making using computational behavioral modeling, neurophysiology, and neuroimaging.

    Dr. Ramayya has published in numerous peer-reviewed journals, including the Journal of Neuroscience, NeuroImage, and Cerebral Cortex. He has also presented his work at national and international meetings, including those for the American Association of Neurological Surgeons and the Pan Philadelphia Neurosurgery Conference.

  • Kavitha Ramchandran

    Kavitha Ramchandran

    Clinical Professor, Medicine - Oncology

    Current Research and Scholarly InterestsMy research focuses on innovative models of care delivey to understand how to integrate primary and specialist palliative care. We also do work in palliative care education and how to scale our education to be impactful and sustainable. We are evaluating online models.

    In cancer care I do research on novel therapeutics in thoracic malignancies including immunotherapy, new targeted agents, and new sequencing of approved drugs.

  • Meghan Ramsey

    Meghan Ramsey

    Clinical Associate Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine

    BioDr. Meghan Ramsey is a Clinical Associate Professor in the Division of Pulmonary, Allergy, and Critical Care Medicine. She received her undergraduate degree from Lafayette College in Pennsylvania with a major in Neuroscience. She then attended Stanford University for medical school where she stayed to complete her internal medicine residency, and pulmonary/critical care fellowship. Her clinical time is split between the inpatient setting in the medical ICU and the ambulatory setting in Interventional Pulmonology with a focus on thoracic malignancies. Outside of her clinical time she has a dedicated commitment to teaching, serving as a mentor for residents and fellows, as well as leading as a co-director the pulmonary physiology course for medical students.

  • Jasmine Rana, MD

    Jasmine Rana, MD

    Clinical Assistant Professor, Dermatology

    BioDr. Jasmine Rana is a Clinical Assistant Professor of Dermatology at Stanford, Director of the Nail Disorders Clinic, and member of the supportive oncodermatology group at the Stanford Cancer Center. Her clinical interests include nail side effects from anti-cancer therapy, tumors of the nail unit, longitudinal melanonychia, brittle nails, fungal nail infection, nail psoriasis, nail lichen planus, nail surgery, and cutaneous toxicities associated with anti-cancer treatments and organ transplantation.

    She received her Bachelor of Arts degree summa cum laude from Wellesley College and received a Doctor of Medicine and Masters in Education from Harvard Medical School. She completed residency in dermatology at Stanford University Medical Center and served as chief resident in her final year.

  • Devin Rand-Giovannetti

    Devin Rand-Giovannetti

    Clinical Assistant Professor, Psychiatry and Behavioral Sciences

    BioDr. Devin Rand-Giovannetti is a licensed psychologist who specializes in the treatment of eating disorders and trauma. She received her BA with Honors from Wellesley College and her doctorate in Clinical Psychology from the University of Hawaiʻi at Mānoa. She completed her clinical internship at the Palo Alto Veterans Affairs Medical Center and her postdoctoral fellowship at Stanford University's School of Medicine. She provides psychotherapy and supervision from a cognitive-behavioral framework. Dr. Rand-Giovannetti currently serves patients through the PTSD and Eating Disorders Clinics at Stanford School of Medicine.

  • Thomas Rando, MD, PhD

    Thomas Rando, MD, PhD

    Professor of Neurology and Neurological Sciences, Emeritus

    Current Research and Scholarly InterestsOur laboratory studies the molecular mechanisms regulating stem cell function, the effects of aging on skeletal muscle and skeletal muscle stem cells, and the pathogenesis and experimental therapeutics for hereditary muscle diseases, specifically the muscular dystrophies.

  • Julia Raney

    Julia Raney

    Clinical Assistant Professor, Pediatrics - Adolescent Medicine

    Current Research and Scholarly InterestsAdolescents are dying from drug overdoses at unprecedented rates, largely secondary to fentanyl contamination in the drug supply. A Youth Overdose Prevention Toolkit for school-based health centers is needed to combat this trend. The toolkit should include key stakeholder-informed harm reduction approaches that focus on reducing injury or death from fentanyl and other opioids without exclusively recommending abstinence; this approach is evidence-based and critical to saving lives.

  • Anoop Rao

    Anoop Rao

    Clinical Associate Professor, Pediatrics - Neonatal and Developmental Medicine

    Current Research and Scholarly InterestsWearable senors, unobtrusive vital sign monitoring, natural language processing/text mining

  • Jianghong Rao

    Jianghong Rao

    Professor of Radiology (Molecular Imaging Program at Stanford) and, by courtesy, of Chemistry

    Current Research and Scholarly InterestsProbe chemistry and nanotechnology for molecular imaging and diagnostics